Purpose: We prospectively assessed whether enhancement characteristics on dynamic magnetic resonance (MR) imaging could distinguish indeterminate pulmonary nodules.
Introduction
Solitary pulmonary nodules are commonly observed on chest radiographs. Morphologic analysis based on assessment of size, shape, and internal characteristics using computed tomography (CT) has been the mainstay in evaluating indeterminate pulmonary nodules. A nodule with corona radiata appearance is likely to be malignant. 1 Although the presence of intranodular fat or calciˆcation, lack of growth for at least 2 years, and disappearance or signiˆcant regression of nodules after initiation of antibacterial or steroid therapy are generally accepted as reliable signs of benignancy, otherˆnd-ings have not proven very useful in diŠerentiating malignant and benign nodules. 1 Dynamic evaluation with CT or magnetic resonance (MR) imaging has demonstrated stronger enhancement of malignant neoplasms than benign nodules, [2] [3] [4] [5] and the overlap of early enhancement characteristics between malignant neoplasms and active in‰ammatory nodules by dynamic MR imaging or CT is recently reported. [6] [7] [8] More recently, researchers using MR imaging reported the absence of washout in most active in‰ammatory and benign nodules at the second or fourth minute from initiation of contrast injection. 9, 10 However, these dynamic studies were retrospective, and washout characteristics after 4 min were unclear. Therefore, there is no evidence to indicate whether the characteristics of early enhancement and washout using dynamic MR imaging could distinguish indeterminate pulmonary nodules.
It has been conˆrmed that a series of CT scans during early enhancement followed by washout may result in higher radiation exposure, 7 but dynamic MR imaging involves no exposure to radiation and has inherent high contrast resolution. 11 We prospectively assessed whether we could distinguish indeterminate pulmonary nodules using dynamic MR imaging based on early or late peak enhancement with or without washout characteristics with super-delayed phases of 8 and 12 min after contrast injection.
Materials and Methods

Subjects
Our institutional review board approved this study, and informed consent was obtained from all patients. Between December 2005 and December 2009, we selected for study patients meeting the following criteria: presence of a solid solitary pulmonary nodule or mass by CT that needed further evaluation; absence of calciˆcation or deˆnite fat attenuation of the nodule or mass by CT; absence of histological diagnosis; absence of contraindications to the administration of contrast material; absence of history of immunodeˆciency; and ability to undergo the procedure. We included only nodules of 6-mm or larger diameter as calculated using the mean of the long-and short-axis diameters of the nodules or masses on CT. Single (n＝14) or 64-row (n＝37) helical CT scans (X-Vigor or Aquilion, Toshiba Medical, Tokyo, Japan) were performed and contiguous 10-to one-mm (median, 5-mm) scans were obtained during breath holding and full inspiration from the lung apex to the lung base with patients in supine position. Rotation time was 1.0 or 0.6 ms, and tube current was 120 kVp at 200 or 300 mA. Weˆnally evaluated 51 pulmonary nodules in 51 consecutive patients (11 female, 40 male; aged 27 to 89 years, mean age, 64 years) who underwent dynamic MR imaging in our hospital's radiology department.
MR imaging techniques
All examinations were performed with a commercially available 1.5-tesla whole-body MR unit (Intera NovaDual; Philips Medical Systems, Best, The Netherlands) with a maximum gradient strength of 33 mT/m and slew rate of 160 mT/m/s using a SENSE body coil. Patients were supine throughout examination. T 1 -weighted axial (repetition time [TR] , 330 to 1,000 ms; echo time [TE], 12 to 15 ms) turbo spin-echo and coronal (TR, 70 to 150 ms, TE, 2.3 and 4.6 ms) gradient-echo MR images without fat suppression were acquired for lesion localization.
Dynamic MR images were acquired in the sagittal plane across the maximal diameter of the nodules at 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 120, 150, 180, 210, 240, 360, 480, 600, 720, and 840 s after injection of contrast material using a T 1 -weighted in-phase 3-dimensional gradient-echo MR sequence (TR, 2.3 ms; TE, 1.0 ms; 159‰ip angle; slab thickness, 40 mm; slice thickness, 4 mm; matrix size, 208 ×129; and acquisition time, 3.7 s). Every measurement required a short inspiration breath hold of 4 s. In contrast to transverse images, sagittal images can depict nodules with all breath holds, even for slightly diŠerent inspiration levels, because the lateral to medial positional change of the nodules is minor. 5 A bolus injection lasting 4 s of gadodiamide (Daiichi Sankyo Co., Ltd., Tokyo, Japan; before June 2007) or gadoteridol (Eisai Co., Ltd., Tokyo, Japan; after July 2007) at a dose of 0.1 mmol per kilogram of body weight was administered through an antecubital vein followed by administration of 20 mL of 0.9z saline at the same rate through an automatic infusion system (Nemoto Kyorindo Co. Ltd., Tokyo, Japan). All 51 dynamic MR imaging studies were completed successfully without adverse eŠects.
MR imaging analysis
Soon after dynamic MR imaging and beforeˆnal diagnosis, we prospectively assessed morphologic enhancement patterns, kinetic parameters, including peak rate, peak time, and steepest slope, and washout of nodules. A radiologist with 23 years' experience who was blinded to patient CT features and clinical data measured regions of interest (ROI) of each nodule. As described in previous studies, we selected a large ROI to incorporate solid-appearing parts of a nodule and to exclude obvious necrotic, cystic, and cavitary areas. 2, 7, 8 We selected the most enhanced area within the nodules as the ROI and made the ROI as large as possible to include at least half the lesion to minimize noise. We evaluated morphologic enhancement patterns on the image at the time of peak enhancement and classiˆed its pattern as either homogeneous (enhancement uniform throughout the nodule), heter-ogeneous (irregularly enhanced), peripheral (clear enhancement of the nodule periphery), or rim (thin layer [capsule] of enhancement limited to the outer margin of the nodule).
We divided the signal intensity of each ROI by the signal intensity at 0 s after injection of contrast material as RSI T ＝SI T /SI 0 , where RSI T represents the relative signal intensity at T seconds after injection of contrast material, SI T is the signal intensity at T seconds, and SI 0 is the signal intensity at 0 s. To avoid measurement errors, we then calculated the average of 3 contiguous RSI T values as [RSI (at prior time T)＋RSI T ＋RSI (at next time T)]/3. Thê rst and last averages of the 3 contiguous RSI values, RSI 0 and RSI 840 , were not used. From the time-signal intensity curve of the average of the 3 contiguous RSI T values, we measured the peak of their average values during the observation time (peak rate), the time at which the peak rate of their average values (10 to 720 s) occurred (peak time), and the highest slope (steepest slope), deˆned as [(average of 3 contiguous RSI T -average of 3 contiguous RSI (at prior time T)×100z]/[T-prior time T]. 12 By consensus, a radiologist with 3 years' experience and pulmonologist with 4 years' experience, both blinded to patient CT features and clinical data, evaluated washout from the time-signal intensity curves of the mean RSI T at 2, 4, 8, and 12 min after injection of contrast material. Washout refers to the reduction of contrast in nodules during a variable period after the intravenous injection of a bolus of contrast material. 7 From the time-signal intensity curve, we categorized the degree of washout for each nodule. We deˆned washout as reduced contrast after peak enhancement with a 10z or more decrease in signal intensity of peak enhancement during the designated period, 8 no washout as either no delayed washout or minimal washout with less than a 10z decrease in signal intensity during that period. Absence of signiˆcant enhancement was diˆned as enhancement of less than 1.5 times of the peak rate.
Final diagnosis
Final diagnoses were made histologically, microbiologically, or clinically. Blinded to results of dynamic MR imaging, a pathologist with 10 years' experience interpreted the histologic diagnoses of specimens from surgery or biopsy. A pulmonologist with 19 years' experience, also blinded to the results of dynamic MR imaging, made clinical diagnoses using clinical data and the results of radiological follow-up studies. Nodules or masses were classiˆed as active in‰ammatory nodules if a diagnosis was conˆrmed histologically (organizing pneumonia, etc.) or microbiologically (bacteria, fungus, and mycobacterium) or if the nodules were established with radiological follow-up studies that revealed disappearance or signiˆcant regression of the nodules after initiation of antibacterial or steroid therapy. 12 Pulmonary nodules were classiˆed as benign if diagnosis was conˆrmed histologically or microbiologically or if radiologicˆndings showed no growth over at least 2 years' follow-up (＝gran-uloma). 4 Tuberculomas were distinguished from active tuberculosis on the basis of absence of change for more than 2 years after the initiation of antituberculosis therapy and classiˆed as benign pulmonary nodules. 6, 8 
Statistical analysis
To distinguish indeterminate pulmonary nodules, we used Mann-Whitney's U test and KruskalWallis test to evaluate signiˆcant diŠerences in morphologic enhancement patterns, kinetic parameters, and washout based on the prospectively analyzed parameters. Pº0.05 was considered signiˆcant diŠerence. We used Spearman's correlation test to evaluate the relationship between washout characteristics and time to peak enhancement. Statistical analyses were performed with SPSS software (version 13.0, SPSS, Chicago, IL).
Results
Subjects andˆnal diagnoses
Among 51 nodules, 25 were malignant (mean diameter, 27.5 mm; range, 13 to 55 mm), 26 were nonmalignant (19.7 mm, 6 to 60 mm); 12 were active in‰ammatory (23.3 mm, 12 to 60 mm), and 14 were benign (16.5 mm, 6 to 28 mm). Final diagnoses of 41 of the 51 nodules were made histologically or microbiologically by surgery (n＝14), biopsy (n＝25), or gastric ‰uid analysis (n＝2). Diagnoses of bacterial pneumonia (n＝2) and organizing pneumonia (n＝2) were conˆrmed by disappearance of nodules after initiation of antibacterial or steroid therapy. Wegener's granulomatosis was diagnosed by paranasal sinus mass, pulmonary nodule, histopathology of purpura, and elevated proteinase-3 antineutrophil cytoplasmic antibodies. The pulmonary nodule disappeared after initiation of immunosuppressive therapy. Two cases of mycobacterioses diagnosed microbiologically, one by biopsy and the other by gastric ‰uid analysis, showed signiˆcant regression of the nodules after initiation of treatment for mycobacterial infection and were classiˆed as active in‰ammatory pulmonary nodules. Five granulomas were diagnosed 
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based on radiologic follow-up studies that revealed no change over 2 years. Three tuberculomas diagnosed microbiologically, two by biopsy and one by gastric ‰uid analysis, showed no change for more than 2 years after initiation of antituberculosis therapy, and the tuberculomas were classiˆed as benign pulmonary nodules (Table 1) .
MR imaging analysis and statistical analysis
There was no signiˆcant diŠerence in morphologic enhancement between malignant and nonmalignant nodules and among malignant, active in‰ammatory, and benign nodules (Tables 2, 3 ). However, heterogeneous enhancement patterns tended to be less common in benign nodules (P＝ 0.054).
Diameters were signiˆcantly larger for malignant nodules than nonmalignant (P＝0.01) and benign (Pº0.01) nodules. Patients with malignant nodules were signiˆcantly older than those with nonmalignant (P＝0.01) and active in‰ammatory (P＝0.02) nodules. However, dynamic MR imaging characteristics, such as peak rate, peak time, steepest slope, and washout at 2, 4, 8, and 12 min, showed no signiˆcant diŠerence between malignant and nonmalignant nodules and among malignant, active in‰ammatory, and benign nodules (Tables 4,  5 ; Figs. 1, 2) .
Two nodules showed no signiˆcant enhancement and wereˆnally diagnosed benign.
Washout characteristics at two (r＝-0.64, Pº 0.01) and four (r＝-0.41, Pº0.01) minutes following injection of contrast material and earlier peak time of nodular enhancement were signiˆcant-ly related. However, there was no relationship among washout characteristics at 8 min (r＝-0.19, P＝0.18), 12 min (r＝-0.15, P＝0.30), and earlier peak time.
Discussion
We prospectively assessed indeterminate pulmonary nodules using dynamic MR imaging based on characteristics of early or late peak enhancement with or without washout. Characteristics of early peak enhancement did not distinguish nodules as malignant or active in‰ammatory, and late peak enhancement did not always indicate benign pulmonary nodules. Characteristics of washout did not su‹ciently distinguish malignant from nonmalignant nodules. Characteristics of no washout did not indicate benignancy. In addition, morphologic enhancement patterns were not su‹cient to diŠerentiate malignant and nonmalignant nodules. These characteristics demonstrated the limited utility of dynamic MR imaging for distinguishing malignant from active in‰ammatory or benign nodules.
Zou and associates 10 reported the steepest slope of benign pulmonary nodules to be signiˆcantly lower than that of malignant or active in‰ammato-ry nodules. And overlap of early enhancement characteristics between lung cancer and active in‰am-matory nodules by dynamic MR imaging or CT is reported. [6] [7] [8] However, our prospective assessment showed overlap of nodular kinetic parameters, which include peak rate, peak time, and steepest slope, between benign pulmonary nodules and lung cancer/active in‰ammatory nodules. This is partly because benign pulmonary nodules may have some of the characteristics of active in‰ammation. Granuloma and tuberculoma are considered to be less active in‰ammatory nodules, 3, 4 and in our study, granuloma and tuberculoma were the primary constituents of benign pulmonary nodules,ˆndings similar to those of other reports. 2, 3, 6, 8, 10 Several recent dynamic MR imaging studies have examined early enhancement followed by washout in pulmonary nodules 5, 8, 9 and focused only secondarily on washout after contrast enhancement. They 
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reported the high speciˆcity of washout for malignancy 5 and the possibility that no washout might suggest benignancy. 8, 9 In our study, however, washout characteristics indicated neither malignancy nor active in‰ammation, and the case of no washout showed no characteristics of benignancy. Discrepancies among ourˆndings and those of other researchers re‰ect the signiˆcant relationship between washout characteristics and earlier peak time; early peak enhancement showed no characteristics of malignancy or active in‰ammation, so washout characteristics did not indicate malignancy or active in‰ammation. Late peak enhancement, which did not always indicate benign pulmonary nodules, suggested that the case with no washout showed no characteristics of benignancy. The reasons for the relationship between early peak enhancement and washout are unclear, but rapid blood ‰ow from arteries to veins may be a primary cause. Zou's group 10 relates early enhancement of pulmonary nodules to neovascularity or capillary dilatation in their histological examination,ˆndings that suggest such ‰ow in the pulmonary nodules.
We found signiˆcant relationship between early peak time of nodular enhancement and washout at 2 or 4 min but poor relationship at 8 or 12 min. The reasons for this result are unclear, but a primary reason is considered to be that washout characteristics at 8 or 12 min may re‰ect systemic washout of contrast materials as well as washout of nodular enhancement, whereas washout at 2 or 4 min might primarily indicate only washout of nodular enhancement.
The absence of signiˆcant enhancement of pulmonary nodules is reported a strong predictor of benignancy for CT [2] [3] [4] and MR imaging 8 but rare in dynamic MR imaging series, 8, 9 results corroborating ours. Because of its inherent superior contrast resolution, MR imaging is better than CT for depicting slight contrast enhancement. 11 In addition, we selected the ROI to incorporate solid-appearing parts of a nodule and to exclude obvious necrotic, cystic, and cavitary areas, 9 which could also be a primary reason few nodules showed no signiˆcant enhancement.
The utility of morphologic enhancement patterns for diŠerentiating malignant from benign pulmonary nodules is reported. 5, 8, 9 However, these reports do not agree regarding whether peripheral enhancement indicates malignancy 9 or benignancy, 5, 8 perhaps because only one of the studies reports the timing of assessments of morphologic enhancement patterns. 8 We observed that some pulmonary nodules demonstrated early peripheral enhancement with late heterogeneous or homogeneous enhancement, 9 so the timing of assessment of the nodules could aŠect patterns of morphologic enhancement. Assessing patterns on images at the time to peak enhancement, we found the morphologic enhancement patterns insu‹cient for diŠerentiating between malignant and active in‰ammatory/benign nodules,ˆndings contrary to those of Kono's group. 8 Statistical analysis demonstrated signiˆcant difference between nodular diameter and patient's age between malignant and nonmalignant pulmonary nodules but no apparent direct relationship to the characteristics of dynamic MR imaging. In general, the larger the nodule, the more likely it is malignant, 1 and most patients with lung cancer are older than 65 years at diagnosis. 13 Therefore, our study group of patients with lung cancer may not diŠer from the general group of patients with lung cancer.
Our study has several limitations. First,ˆnal diagnoses were conˆrmed by histology or microbiology in only 80.4z (41/51) of patients and by clinical data and radiologic follow-up in the remaining cases, 5 cases each of active in‰ammation and benignancy. However, not all active in‰ammatory or benign pulmonary nodules require histologic conˆrmation. We introduced clinical data and radiologic follow-up conˆrmation to avoid selection bias that would exclude mainly nonmalignant pulmonary nodules from the study sample. Second, this preliminary study analyzed only a small number of pulmonary nodules; study of more nodules may have shown signiˆcant diŠerences between malignant and nonmalignant pulmonary nodules even though they have fewer diŠerences that may make it hard to distinguish indeterminate pulmonary nodules in practice. Third, we used the average of 3 contiguous relative signal intensities to draw the time-signal intensity curve. Without averaging, the time-signal intensity curves were often zigzags, which may have been caused by measurement errors in this prospective study. The averaging of 3 contiguous relative signal intensities is one way to smooth these curves.
Conclusion
In conclusion, we evaluated indeterminate pulmonary nodules using dynamic MR imaging, focusing on characteristics of early enhancement and washout. Our results showed no predictive value of early or late peak enhancement with or without washout for diŠerentiating malignant from active in‰ammatory/benign pulmonary nodules. Therefore, dynamic MR imaging studies, when prospectively assessed, are inadequate for distinguishing indeterminate pulmonary nodules.
